MA28179A1 - Nouveau compose, compositions correspondantes, methodes de fabrication et/ou de traitement - Google Patents

Nouveau compose, compositions correspondantes, methodes de fabrication et/ou de traitement

Info

Publication number
MA28179A1
MA28179A1 MA29057A MA29057A MA28179A1 MA 28179 A1 MA28179 A1 MA 28179A1 MA 29057 A MA29057 A MA 29057A MA 29057 A MA29057 A MA 29057A MA 28179 A1 MA28179 A1 MA 28179A1
Authority
MA
Morocco
Prior art keywords
methods
making
processing
new compound
preparation
Prior art date
Application number
MA29057A
Other languages
English (en)
Inventor
Orco Philip C Dell
Ann Marie Diederich
Qiaogang Su
Jeffrey Lee Wood
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MA28179A1 publication Critical patent/MA28179A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composé nouveau, compositions correspondantes, procédés de préparation et/ou méthodes de traitement II est présenté une forme cristalline nouvelle de pentahydrate de monochlorhydrate de topotécan qui est un pentahydrate de monochrlohydrate de 10[(diméthyl-amino)méthyl] -4-éthyl-4, 9-dihydroxy- lH-pyrano [31 , 4 ' :6,7] -indolizino[1,2-b]quinoléine-3,14(4H, 12H)dione, des compo¬sitions pharmaceutiques correspondantes, des procédés pour leur préparation et/ou des méthodes pour leur utilisation à des fins de traitement de maladies virales et/ou en rapport avec le cancer.
MA29057A 2003-11-12 2006-05-24 Nouveau compose, compositions correspondantes, methodes de fabrication et/ou de traitement MA28179A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51916003P 2003-11-12 2003-11-12
US52457403P 2003-11-24 2003-11-24

Publications (1)

Publication Number Publication Date
MA28179A1 true MA28179A1 (fr) 2006-09-01

Family

ID=34594951

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29057A MA28179A1 (fr) 2003-11-12 2006-05-24 Nouveau compose, compositions correspondantes, methodes de fabrication et/ou de traitement

Country Status (16)

Country Link
US (2) US7754733B2 (fr)
EP (1) EP1689400A4 (fr)
JP (1) JP2007510751A (fr)
KR (1) KR20060122847A (fr)
CN (1) CN1913897B (fr)
AR (1) AR046579A1 (fr)
AU (1) AU2004289318B2 (fr)
BR (1) BRPI0416366A (fr)
CA (1) CA2545876A1 (fr)
IL (1) IL175369A (fr)
IS (1) IS8491A (fr)
MA (1) MA28179A1 (fr)
NO (1) NO20062616L (fr)
RU (1) RU2352572C2 (fr)
TW (1) TWI333492B (fr)
WO (1) WO2005046608A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR046579A1 (es) * 2003-11-12 2005-12-14 Smithkline Beecham Corp Compuesto cristalino de topotecan, composicion farmaceutica que lo comprende, procedimiento para prepararlo y su uso para preparar dicha composicion farmaceutica
KR20080068052A (ko) * 2005-10-10 2008-07-22 씨아이피엘에이 엘티디. 신규의 결정형
US7547785B2 (en) * 2005-12-26 2009-06-16 Dr. Reddy's Laboratories Limited Process for preparing topotecan
US7977483B2 (en) * 2007-04-11 2011-07-12 Scinopharm Taiwan, Ltd. Process for making topotecan
WO2008130534A1 (fr) * 2007-04-19 2008-10-30 Scinopharm Taiwan Ltd. Formes cristallines de chlorhydrate de topotécan et leurs procédés de préparation
US7572803B2 (en) * 2007-10-25 2009-08-11 The Christus Stehlin Foundation For Cancer Research Hydrated crystalline esters of camptothecin
ITMI20072268A1 (it) 2007-12-04 2009-06-05 Antibioticos Spa Polimorfi cristallini di topotecan cloridrato con elevato grado di purezza e metodi per la loro preparazione
US20250295771A1 (en) 2022-05-11 2025-09-25 Celgene Corporation Methods and uses related to t cell therapy and production of same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JP2848958B2 (ja) * 1990-09-28 1999-01-20 スミスクライン・ビーチャム・コーポレイション 水溶性カンプトテシン類似体、方法および手段
FR2790261B1 (fr) * 1999-02-26 2004-09-10 Sod Conseils Rech Applic Nouveaux analogues optiquement purs de la camptothecine et leurs procedes de preparation
FR2757514B1 (fr) * 1996-12-20 1999-02-12 Sod Conseils Rech Applic Nouveaux analogues de la camptothecine, des procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
IT1282673B1 (it) * 1996-02-23 1998-03-31 Ist Naz Stud Cura Dei Tumori Derivati della camptotecina e loro uso come agenti antitumorali
PT847397E (pt) * 1996-12-19 2003-01-31 Reddys Lab Ltd Dr Analogos de anel c soluveis em agua de 20(s)-camptotecinac
AR013261A1 (es) * 1997-08-01 2000-12-13 Smithkline Beecham Corp Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
IL160982A0 (en) * 2001-09-25 2004-08-31 Reddys Lab Ltd Dr Salts of 20(s)-camptothecin, processes for the preparation thereof and pharmaceutical compositions containing the same
US7049322B2 (en) * 2002-02-21 2006-05-23 Supergen, Inc. Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
AR046579A1 (es) * 2003-11-12 2005-12-14 Smithkline Beecham Corp Compuesto cristalino de topotecan, composicion farmaceutica que lo comprende, procedimiento para prepararlo y su uso para preparar dicha composicion farmaceutica
KR20080068052A (ko) 2005-10-10 2008-07-22 씨아이피엘에이 엘티디. 신규의 결정형
US7547785B2 (en) * 2005-12-26 2009-06-16 Dr. Reddy's Laboratories Limited Process for preparing topotecan
WO2008130534A1 (fr) 2007-04-19 2008-10-30 Scinopharm Taiwan Ltd. Formes cristallines de chlorhydrate de topotécan et leurs procédés de préparation
ITMI20072268A1 (it) * 2007-12-04 2009-06-05 Antibioticos Spa Polimorfi cristallini di topotecan cloridrato con elevato grado di purezza e metodi per la loro preparazione

Also Published As

Publication number Publication date
US8158645B2 (en) 2012-04-17
US20070117832A1 (en) 2007-05-24
JP2007510751A (ja) 2007-04-26
WO2005046608B1 (fr) 2005-12-29
IS8491A (is) 2006-05-30
US7754733B2 (en) 2010-07-13
IL175369A (en) 2012-03-29
BRPI0416366A (pt) 2007-03-13
TW200530250A (en) 2005-09-16
CA2545876A1 (fr) 2005-05-26
AR046579A1 (es) 2005-12-14
TWI333492B (en) 2010-11-21
NO20062616L (no) 2006-07-12
CN1913897A (zh) 2007-02-14
CN1913897B (zh) 2010-08-11
AU2004289318B2 (en) 2010-04-29
KR20060122847A (ko) 2006-11-30
RU2006120422A (ru) 2007-12-27
IL175369A0 (en) 2008-04-13
RU2352572C2 (ru) 2009-04-20
EP1689400A4 (fr) 2006-12-27
WO2005046608A3 (fr) 2005-11-03
US20100210677A1 (en) 2010-08-19
EP1689400A2 (fr) 2006-08-16
WO2005046608A2 (fr) 2005-05-26
AU2004289318A1 (en) 2005-05-26

Similar Documents

Publication Publication Date Title
CA2442557A1 (fr) Derives dihydro-benzo¬b|¬1,4|diazepin-2-one utilises comme antagonistes de mglur2(ii)
WO2005049581A8 (fr) Derives de pyridazine-3(2h)-ones et utilisation en tant qu'inhibiteurs de pde4
HUP0303128A2 (hu) O-dezmetil-venlafaxin új szukcinátsója, eljárás az előállításukra, alkalmazása és ezt tartalmazó gyógyszerkészítmény
MY132106A (en) New pyridazin-3(2h)-one derivatives
IL164974A0 (en) Novel compounds and their use
HUP0400343A2 (hu) Ciklopropil-indol-származékok mint szelektív szerotonin-újrafelvétel inhibitorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
WO2000055124A3 (fr) Composes et compositions utilises comme inhibiteurs de protease
WO2004108715A8 (fr) Benzo[b]thiophenes a substitution 3-aryloxy et 3-heteroaryloxy en tant qu'agents therapeutiques a activite pi3k
NO20000313D0 (no) Nye forbindelser
SE0104341D0 (sv) New use
JP2002520273A5 (fr)
JP2007516193A5 (fr)
GT200200081A (es) Sal citrato de 5,8,14-triazatetraciclo[10.3.1.0 2,11.0 4,9] hexadeca-2(11),3,5,7,9-pentaeno y composiciones farmaceuticas de la misma
GB0322510D0 (en) Novel compounds
TW200531688A (en) Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
JP2004538278A5 (fr)
AU2002256334A1 (en) Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino(2,3-f)quinoxaline
WO2005046608A3 (fr) Nouveau compose, compositions correspondantes, methodes de fabrication et/ou de traitement
WO2005013935A3 (fr) Nouvelle composition
WO2003045940A3 (fr) Composes therapeutiques
ATE297926T1 (de) Hexahydropyrazino(1'2':1,6)-pyrido(3,4-b)indole 1,4-dion-derivate zur behandlung von cardiovaskulären erkrankungen und erektionsstörungen
WO2003045917A3 (fr) Antagonistes vii du recepteur ccr3
WO2003045952A3 (fr) Composes hexacycliques
SE0100297D0 (sv) New compounds
SE0100296D0 (sv) New compounds